104 related articles for article (PubMed ID: 11504817)
1. Efficacy of the novel selective platelet-derived growth factor receptor antagonist CT52923 on cellular proliferation, migration, and suppression of neointima following vascular injury.
Yu JC; Lokker NA; Hollenbach S; Apatira M; Li J; Betz A; Sedlock D; Oda S; Nomoto Y; Matsuno K; Ide S; Tsukuda E; Giese NA
J Pharmacol Exp Ther; 2001 Sep; 298(3):1172-8. PubMed ID: 11504817
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation.
Sparwel J; Vantler M; Caglayan E; Kappert K; Fries JW; Dietrich H; Böhm M; Erdmann E; Rosenkranz S
Cardiovasc Res; 2009 Mar; 81(4):758-70. PubMed ID: 19074160
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
6. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling.
Lamy S; Beaulieu E; Labbé D; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R
Carcinogenesis; 2008 May; 29(5):1033-41. PubMed ID: 18339683
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC
Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604
[TBL] [Abstract][Full Text] [Related]
8. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
Beebe JS; Jani JP; Knauth E; Goodwin P; Higdon C; Rossi AM; Emerson E; Finkelstein M; Floyd E; Harriman S; Atherton J; Hillerman S; Soderstrom C; Kou K; Gant T; Noe MC; Foster B; Rastinejad F; Marx MA; Schaeffer T; Whalen PM; Roberts WG
Cancer Res; 2003 Nov; 63(21):7301-9. PubMed ID: 14612527
[TBL] [Abstract][Full Text] [Related]
10. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
Matsuno K; Ushiki J; Seishi T; Ichimura M; Giese NA; Yu JC; Takahashi S; Oda S; Nomoto Y
J Med Chem; 2003 Nov; 46(23):4910-25. PubMed ID: 14584942
[TBL] [Abstract][Full Text] [Related]
11. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.
Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553
[TBL] [Abstract][Full Text] [Related]
12. A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.
Patel N; Sun L; Moshinsky D; Chen H; Leahy KM; Le P; Moss KG; Wang X; Rice A; Tam D; Laird AD; Yu X; Zhang Q; Tang C; McMahon G; Howlett A
J Pharmacol Exp Ther; 2003 Sep; 306(3):838-45. PubMed ID: 12766257
[TBL] [Abstract][Full Text] [Related]
13. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
14. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells.
Bansal R; Magge S; Winkler S
J Neurosci Res; 2003 Nov; 74(4):486-93. PubMed ID: 14598292
[TBL] [Abstract][Full Text] [Related]
16. Screening of Kit inhibitors: suppression of Kit signaling and melanogenesis by emodin.
Lee SJ; Jeong D; Park WK; Kong JY; Choi G; Kim H; Kang S; Cho H
Phytother Res; 2010 Feb; 24(2):308-12. PubMed ID: 19585486
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases.
Zaman GJ; Vink PM; van den Doelen AA; Veeneman GH; Theunissen HJ
Biochem Pharmacol; 1999 Jan; 57(1):57-64. PubMed ID: 9920285
[TBL] [Abstract][Full Text] [Related]
18. The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates.
Giese NA; Marijianowski MM; McCook O; Hancock A; Ramakrishnan V; Fretto LJ; Chen C; Kelly AB; Koziol JA; Wilcox JN; Hanson SR
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):900-9. PubMed ID: 10195916
[TBL] [Abstract][Full Text] [Related]
19. The Crataegus extract WS 1442 inhibits balloon catheter-induced intimal hyperplasia in the rat carotid artery by directly influencing PDGFR-beta.
Fürst R; Zirrgiebel U; Totzke F; Zahler S; Vollmar AM; Koch E
Atherosclerosis; 2010 Aug; 211(2):409-17. PubMed ID: 20435310
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of platelet-derived growth factor by perivascular gene transfer attenuates adventitial cell migration after vascular injury: new tricks for old dogs?
Mallawaarachchi CM; Weissberg PL; Siow RC
FASEB J; 2006 Aug; 20(10):1686-8. PubMed ID: 16790526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
